New Enterprise Associates Inc. is likely to open a Boston office within the next half a year, General Partner David Mott told the Boston Business Journal.
The fact that it’s Mott – former MedImmune chief and a prominent life sciences investor – saying this suggests the move is all about biotech. His comments to the Boston paper back up this notion: “Boston is winning the biopharma innovation race, versus other geographies.” Mott is based in Maryland.
{iframe}http://www.bizjournals.com/washington/blog/2013/02/neas-expanding-footprint.html{/iframe}